
Dexlansoprazole Injection
| Product/Composition | Dexlansoprazole Injection |
|---|---|
| Strength | 30mg |
| Form | Injection |
| Production Capacity | 1 Million Injection/Month |
| Therapeutic use | GIT Medicine |
| Package Insert/Leaflet | Available upon request |
Dexlansoprazole Injection
-
Type: Acid-suppressing medication
-
Drug Class: Proton Pump Inhibitor (PPI)
-
Form: Sterile solution or lyophilized powder for intravenous (IV) administration
How It Works
-
Dexlansoprazole works by irreversibly blocking the proton pumps in the stomach lining.
-
These pumps produce gastric acid — by shutting them down, dexlansoprazole reduces stomach acid production.
-
This allows the esophagus, stomach, and duodenum to heal from acid-related damage and relieves symptoms.
Common Uses
Although dexlansoprazole is mostly available as oral capsules, its IV form (if available) is used when oral administration is not possible:
-
Gastroesophageal reflux disease (GERD) – especially with erosive esophagitis
-
Peptic ulcer disease (stomach and duodenal ulcers)
-
Prevention of stress-related gastric ulcers in hospitalized patients
-
Hypersecretory conditions such as Zollinger–Ellison syndrome
-
Acute gastrointestinal bleeding (as part of acid suppression therapy to promote clot stability)
Advantages
-
Provides potent and long-lasting acid suppression
-
Dual delayed-release technology (in oral form) allows prolonged control — IV form offers continuous effect when oral route is not feasible
-
May be given once daily, making it convenient
Possible Side Effects
Most are mild and temporary:
-
Headache
-
Nausea, diarrhea, constipation
-
Abdominal pain or bloating
-
Injection site reactions (pain, redness, swelling)
Long-Term or High-Dose Use Risks
-
Low magnesium levels
-
Vitamin B12 deficiency
-
Increased risk of fractures with prolonged use
-
Possible increased risk of certain infections (e.g., Clostridium difficile) due to reduced stomach acid
Precautions
-
Should be used cautiously in patients with liver impairment (dose adjustment may be needed)
-
Long-term use should be monitored to prevent nutrient deficiencies
-
Should only be used IV when oral therapy is not possible, then switched to oral when feasible
-
Monitor for drug interactions (may affect absorption of drugs needing stomach acid, like ketoconazole)